Global Lifecycle Management Support Strengthened Portfolio Control for a Biopharma Company.
A biopharma company needed structured lifecycle management support for its pharmaceutical portfolio across various global markets. Freyr delivered comprehensive LCM support aimed at streamlining post-approval processes, ensuring submission continuity, and enhancing regulatory oversight across the entire portfolio.


Client Overview
The client is a biopharma company managing a pharmaceutical portfolio across global markets. The engagement focused on providing end-to-end lifecycle management support to sustain compliance and portfolio continuity across regions.
Background
As portfolio complexity increased across markets, the client needed external support to manage post-approval activities more cohesively. The need centered on maintaining continuity, efficiently handling lifecycle submissions, and supporting global portfolio governance.
Services in Scope
End-to-end lifecycle management support for a global pharma portfolio.
Ongoing Regulatory operations to manage post-approval changes and market maintenance activities.
Portfolio support across multiple international markets.

Challenges
Complexity of managing lifecycle activities across multiple markets and products.
Need to maintain continuity and consistency in global post-approval Regulatory work.
Requirement for a scalable support model to handle portfolio-wide LCM demands.
Solution
Freyr provided a centralized LCM support model to coordinate Regulatory maintenance activities across the client’s portfolio. This approach improved visibility, consistency, and operational continuity for post-approval management across global markets.
Assessed the portfolio’s lifecycle management needs across markets and products.
Established a structured support model for Regulatory maintenance and post-approval submissions.
Coordinated portfolio-level activities to improve consistency across markets.
Supported ongoing lifecycle work to sustain compliance and business continuity.
Impact
- Improved management of the client’s pharma portfolio across global markets.
- Strengthened continuity of post-approval Regulatory support.
- Created a scalable model for ongoing lifecycle management.
This engagement shows how a structured LCM model simplifies post-approval complexity across markets. Freyr’s support helped the client shift from fragmented to coordinated global portfolio management, resulting in better operational control and a more sustainable Regulatory framework.